Elizabeth K Do1, Briana Mezuk. 1. Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, P.O. Box 980126, Richmond, VA, USA. doek@vcu.edu
Abstract
BACKGROUND: Bipolar disorder is associated with substance use and misuse. However, to date few studies have examined the relationship between hypomania and substance misuse and dependence in the general population. METHODS: Data come from the National Institute of Mental Health Collaborative Psychiatric Epidemiology Surveys (CPES), a set of multi-stage area probability samples of US adults (N=10,404). Multivariable linear and logistic regression was used to assess the relationship between DSM-IV hypomania and nicotine, alcohol, cannabis, cocaine, and prescription drug use. Models were adjusted for age, gender, education, and marital status. Stratified analyses and interaction terms were used to determine whether the relationship between hypomania and substance misuse varied by race/ethnicity. RESULTS: The 12-month prevalence of hypomania was 0.5%. Hypomania was more common among African Americans (0.9%) relative to non-Hispanic Whites (0.5%) or other race/ethnicities (0.7%). Individuals with hypomania were 3.6 (95% CI: 1.5, 8.5) and 2.9 (95% CI: 1.3, 6.8) times more likely to also meet criteria for alcohol abuse/dependence and drug abuse/dependence relative to individuals without. The relationship between hypomania and substance use outcomes did not vary by race/ethnicity. LIMITATIONS: The primary limitation of this study is its cross-sectional design, which precludes any inference about the causal nature of comorbid hypomania-substance use. CONCLUSIONS: Hypomania is associated with increased likelihood of substance use and dependence/abuse across a broad range of substances. These associations were consistent across racial/ethnic groups. Findings indicate that even sub-syndromal conditions, such as hypomania, are significantly related to substance use and misuse in the community.
BACKGROUND:Bipolar disorder is associated with substance use and misuse. However, to date few studies have examined the relationship between hypomania and substance misuse and dependence in the general population. METHODS: Data come from the National Institute of Mental Health Collaborative Psychiatric Epidemiology Surveys (CPES), a set of multi-stage area probability samples of US adults (N=10,404). Multivariable linear and logistic regression was used to assess the relationship between DSM-IV hypomania and nicotine, alcohol, cannabis, cocaine, and prescription drug use. Models were adjusted for age, gender, education, and marital status. Stratified analyses and interaction terms were used to determine whether the relationship between hypomania and substance misuse varied by race/ethnicity. RESULTS: The 12-month prevalence of hypomania was 0.5%. Hypomania was more common among African Americans (0.9%) relative to non-Hispanic Whites (0.5%) or other race/ethnicities (0.7%). Individuals with hypomania were 3.6 (95% CI: 1.5, 8.5) and 2.9 (95% CI: 1.3, 6.8) times more likely to also meet criteria for alcohol abuse/dependence and drug abuse/dependence relative to individuals without. The relationship between hypomania and substance use outcomes did not vary by race/ethnicity. LIMITATIONS: The primary limitation of this study is its cross-sectional design, which precludes any inference about the causal nature of comorbid hypomania-substance use. CONCLUSIONS:Hypomania is associated with increased likelihood of substance use and dependence/abuse across a broad range of substances. These associations were consistent across racial/ethnic groups. Findings indicate that even sub-syndromal conditions, such as hypomania, are significantly related to substance use and misuse in the community.
Authors: Steven G Heeringa; James Wagner; Myriam Torres; Naihua Duan; Terry Adams; Patricia Berglund Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: James S Jackson; Myriam Torres; Cleopatra H Caldwell; Harold W Neighbors; Randolph M Nesse; Robert Joseph Taylor; Steven J Trierweiler; David R Williams Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: Joshua Breslau; Sergio Aguilar-Gaxiola; Kenneth S Kendler; Maxwell Su; David Williams; Ronald C Kessler Journal: Psychol Med Date: 2005-10-05 Impact factor: 7.723
Authors: Vicent Balanzá-Martínez; Benedicto Crespo-Facorro; Ana González-Pinto; Eduard Vieta Journal: Front Physiol Date: 2015-04-07 Impact factor: 4.566
Authors: Mauro Pettorruso; Luisa De Risio; Marco Di Nicola; Giovanni Martinotti; Gianluigi Conte; Luigi Janiri Journal: Front Psychiatry Date: 2014-12-03 Impact factor: 4.157
Authors: Hanna Dauber; Barbara Braun; Tim Pfeiffer-Gerschel; Ludwig Kraus; Oliver Pogarell Journal: Int J Ment Health Addict Date: 2017-07-11 Impact factor: 3.836